» Articles » PMID: 32277591

Fatal Outcome in a Liver Transplant Recipient with COVID-19

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2020 Apr 12
PMID 32277591
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Liver injury is common in patients with COVID-19, but little is known about its clinical presentation and severity in the context of liver transplant. We describe a case of COVID-19 in a patient who underwent transplant 3 years ago for hepatocellular carcinoma. The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive. His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multiorgan failure. Despite multiple invasive procedures and rescue therapies, he died from the disease. The management of COVID-19 in the posttransplant setting presents complex challenges, emphasizing the importance of strict prevention strategies.

Citing Articles

Impact and management of COVID-19 in liver transplant candidates and recipients.

Liava C, Ouranos K, Chatziioannou A, Kamenidou I, Kofinas A, Vasileiadou S Ann Gastroenterol. 2023; 36(5):477-489.

PMID: 37664224 PMC: 10433260. DOI: 10.20524/aog.2023.0815.


Causal associations between chronic hepatitis B and COVID-19 in East Asian populations.

Liu Z, Song L, Chen J, Zhou Y, Wang Y, Tang L Virol J. 2023; 20(1):109.

PMID: 37264390 PMC: 10232343. DOI: 10.1186/s12985-023-02081-4.


Correlation between COVID-19 and hepatitis B: A systematic review.

He Y, Jiang Z, Wu N, Bian N, Ren J World J Gastroenterol. 2022; 28(46):6599-6618.

PMID: 36569273 PMC: 9782843. DOI: 10.3748/wjg.v28.i46.6599.


COVID-19 and the liver: a narrative review of the present state of knowledge.

Thandassery R, Dranoff J, Perisetti A, Taddei T Transl Gastroenterol Hepatol. 2022; 7:40.

PMID: 36300154 PMC: 9468988. DOI: 10.21037/tgh-20-243.


Transplantation in Asia during the coronavirus disease-19 (COVID-19) pandemic: briefs from member countries of the Asian Society of Transplantation.

Kee T, Jeong J, Ha J, Rashid H, Begum N, Ma M Korean J Transplant. 2022; 34(2):71-77.

PMID: 35769353 PMC: 9188935. DOI: 10.4285/kjt.2020.34.2.71.


References
1.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

2.
Zhu L, Xu X, Ma K, Yang J, Guan H, Chen S . Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant. 2020; 20(7):1859-1863. PMC: 7228349. DOI: 10.1111/ajt.15869. View

3.
Yeh R, Gaver V, Patterson K, Rezk N, Baxter-Meheux F, Blake M . Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers. J Acquir Immune Defic Syndr. 2006; 42(1):52-60. DOI: 10.1097/01.qai.0000219774.20174.64. View

4.
Bouey J . Strengthening China's Public Health Response System: From SARS to COVID-19. Am J Public Health. 2020; 110(7):939-940. PMC: 7287547. DOI: 10.2105/AJPH.2020.305654. View

5.
Feng G, Zheng K, Yan Q, Rios R, Targher G, Byrne C . COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol. 2020; 8(1):18-24. PMC: 7132016. DOI: 10.14218/JCTH.2020.00018. View